Head of Wealth Management
Head of Community Management
Senior Cloud Engineer
Head of Insurance
Full Stack Developer
Rated on 2018-06-14
The economics of token is very unclear. It is explained that this is sort of membership reward token. But it still looks vague how the price could grow. I am not claiming to speak directly about such things in the whitepapers due to the well-known restrictions. But at least the project should add business numbers numbers about "ecosystem growth" in chapter 8 of the WP.
Rated on 2018-07-05
Team: Most of your advisors are not having a linked profile which make investors feel uncertain of their investment. Need to add more verified advisors to convince investors. Vision: If you are doing this right as an ecosystem, it can be a good idea but I don't see it clearly stated in the whitepaper. Product is vague as github does not considered a MVP as most of investors care about their ROI and having low tech knowledge.
Rated on 2018-07-09
I think the team is fairly strong and I like the vision. Supply chain in Health is critical. The WhitePaper is not clear enough, but they they can change healthcare world. Good idea, good team, well thought out, well done.
Rated on 2018-07-13
One of a few ICOs that builds and expands on an existing successful business in Fintech field. The core team has extensive and solid investment and capital background, plus the advisers are reputable in healthcare and medical fields, in the aspect of their research and technology innovation. That makes it a good-matched project combination of “when FinTech meets HealthTech”. The Whitepaper is a bit complicated, to be honest, with layers of “not-so-easy-to-understand” stereoscopic concepts, proficient medical terms and sophisticated financial wordings, while this project is going to be managed and operated by trained professionals and industrial leaders, not amateurs, where it gains much confidence for investors. Highly recommended ICO and an excellent Whitepaper!
Rated on 2018-10-21
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
Aeneas Capital grante Asset Management license by SFC (Hong Kong).
Fund products generate positive returns throughout subprime crisis.
Assets managed by Aeneas deployed into health care private equity and direct investments.
Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK.
Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities; Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices.
Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress); Aeneas Group establishing a full-service banking license in Europe (in progress).
June Initiate Private Sale; Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities; Community investors outreach.
Expand team: Developers; 1st pipeline healthtech; ICO launch; Launch first generation smart wallet & infrastucture (AEN Connect).
Second generation: AENX trading exchange.
Third generation: AENCO prime brokerage platform; Ongoing service & expansion of pipeline HealthTech partners.